| Heading: |
NHS: Drugs |
| Question ID: |
1809181 |
| UIN: |
57256 |
| House: |
Commons |
| Date tabled: |
2025-06-04 |
| Asking Member ID: |
4434 |
| Asking Member display name: |
Stephen Gethins
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Stephen Gethins
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the UK leaving the EU on medicine shortages in the UK. |
| Is named day: |
true |
| Date of holding answer: |
2025-06-10 |
| Date answered: |
2025-06-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The United Kingdom left the European Union on 31 January 2020. The Department has not made a specific assessment of the potential impact on medicine shortages in the UK.Medicine supply chains are complex, global, and highly regulated, and there are a numb... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |